The Joint Corp./$JYNT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.
Ticker
$JYNT
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
590
ISIN
US47973J1025
Website
The Joint Corp. Metrics
BasicAdvanced
$177M
-
-$0.58
1.54
-
Price and volume
Market cap
$177M
Beta
1.54
52-week high
$15.32
52-week low
$9.58
Average daily volume
79K
Financial strength
Current ratio
1.588
Quick ratio
0.583
Long term debt to equity
10.08
Total debt to equity
11.288
Profitability
EBITDA (TTM)
-1.036
Gross margin (TTM)
77.68%
Net profit margin (TTM)
-16.43%
Operating margin (TTM)
-2.62%
Effective tax rate (TTM)
-4.25%
Revenue per employee (TTM)
$90,000
Management effectiveness
Return on assets (TTM)
-1.06%
Return on equity (TTM)
-7.13%
Valuation
Price to revenue (TTM)
3.282
Price to book
8.87
Price to tangible book (TTM)
8.87
Price to free cash flow (TTM)
97.24
Free cash flow yield (TTM)
1.03%
Free cash flow per share (TTM)
11.87%
Growth
Revenue change (TTM)
71.05%
Earnings per share change (TTM)
-24.13%
3-year revenue growth (CAGR)
-14.58%
10-year revenue growth (CAGR)
20.60%
3-year earnings per share growth (CAGR)
17.78%
10-year earnings per share growth (CAGR)
-2.26%
What the Analysts think about The Joint Corp.
Analyst ratings (Buy, Hold, Sell) for The Joint Corp. stock.
The Joint Corp. Financial Performance
Revenues and expenses
The Joint Corp. Earnings Performance
Company profitability
The Joint Corp. News
AllArticlesVideos
The Joint Corp. Signs Binding Agreement to Sell 31 Corporate Clinics in Arizona and New Mexico and to Acquire Regional Developer Rights in the Northwest Region and Refranchises Five Corporate Clinics in the Kansas City Region, Tracking to Become Largest Pure Play Chiropractic Care Franchise System
GlobeNewsWire·7 days ago
The Joint Corp. Names Business Transformation and Growth Expert Scott J. Bowman Chief Financial Officer
GlobeNewsWire·3 weeks ago
The Joint Corp. Announces $5 Million Stock Repurchase Program
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for The Joint Corp. stock?
The Joint Corp. (JYNT) has a market cap of $177M as of July 02, 2025.
What is the P/E ratio for The Joint Corp. stock?
The price to earnings (P/E) ratio for The Joint Corp. (JYNT) stock is 0 as of July 02, 2025.
Does The Joint Corp. stock pay dividends?
No, The Joint Corp. (JYNT) stock does not pay dividends to its shareholders as of July 02, 2025.
When is the next The Joint Corp. dividend payment date?
The Joint Corp. (JYNT) stock does not pay dividends to its shareholders.
What is the beta indicator for The Joint Corp.?
The Joint Corp. (JYNT) has a beta rating of 1.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.